Research Day

The Department hosts an annual Research Day where residents, graduate students and postdoctoral fellows present their research findings. The day begins with a poster session in the morning followed by presentations in the afternoon featuring an honorary guest speaker.

Date: April 17th, 2018, 7:30 a.m. - 5:15 p.m.
Location: Ivey Spencer Leadership Centre, Amphitheatre A

2018 Research Day Program


2018 Honorary Guest Speaker and Judge

Dr. Tom Mikkelsen MD, FRCPC
President and Sicentific Director,
Ontario Brain Institute

Presentation Title:
The Ontario Brain Institute – Team Science for Research with Impact

Tom Mikkelsen, MD, FRCPC

President and Scientific Director, Ontario Brain Institute (OBI)

Tom Mikkelsen, MD, FRCPC is a neurologist and the President and Scientific Director of the Ontario Brain Institute (2015-present). He received his MD from the University of Calgary and completed clinical training in neurology at the Montreal Neurological Institute. Following this, he did post-doctoral training in tumour and molecular biology at the Ludwig Institute for Cancer Research in Montreal and then in La Jolla, California. Since 1992, he has led the brain tumour program at Henry Ford Hospital and was responsible for building the clinical trials program and laboratory of tumour biology. Together with other scientists, he helped assemble the Hermelin Brain Tumor Center, a leader in the understanding of the genetics of brain tumours and in the development of treatments for brain tumours. As Co-Director, he participated in the organization’s development on many levels spanning from face-to-face clinical care to clinical trials and translational and bench research.

Dr. Mikkelsen's presentation, titled The Ontario Brain Institute – Team Science for Research with Impact, focused on the OBIs activities in its next phase, highlighting the opportunities for innovating within the healthcare delivery sector for neurologic disorders. Major themes included; the learning healthcare system, data sharing and partnering with academic, corporate and government players. Shared strategies from the CNS cancer experience were also shared.

Abstract Submission Guidelines

The following information is required to complete the Abstract Submission Form:

  • Name of main contact
  • E-mail address of main contact
  • Indicate whether you will be submitting more than one abstract
  • If more than one abstract is being submitted, rank your abstracts in priority squence
    • 1 = Highest Priority, 5 = Lowest Priority
  • Indicate whether you have a preference between your abstract being presented as a poster or as a platform presentation
  • Abstract title
  • Abstract authors
    • The presenting author should be listed first
    • Include the first and last names of all authors (middle initials are optional)
  • Full abstract
    • Free of spelling and/or gramatical errors
    • Maximum of 1200 characters including spaces

Submit your abstract.